Expands UL Solutions’ global laboratory footprint and enhances commitment to TIC services for electrical safety and connected productsTransaction expected to close in Q4 2026 subject to regulatory ...
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announces ...
NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease ...
CHICAGO, IL / ACCESS Newswire / April 13, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that ...
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and ...
Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with ...
Lung01 Phase 2 trial, with support from IDeate-PanTumor01 Phase 1/2 trialIf approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients ...
Wearable technology has quietly moved beyond being just another category of consumer gadgets—it’s becoming part of how people make everyday decisions. What started with simple step counters has ...
Board-certified plastic surgeon expands his practice to serve patients in Princeton, NJ and Philadelphia, PA. PRINCETON, NJ AND PHILADELPHIA, PA / ACCESS Newswire / April 13, 2026 / Dr. David W.
Appointments add clinical development, translational oncology, company-building, and strategic investment expertise as Orum advances its next wave of degrader-antibody conjugate programsBOSTON & ...
Phase 1 Study Will Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EDP-978 in Healthy VolunteersTopline Data Expected in Q4 2026WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta ...
Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results